NCT02997254 COMparison of Physiological Algorithms for Real-time Evaluation of Atrial Fibrillation
| NCT ID | NCT02997254 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Atrial Fibrillation |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2016-12-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2016-12-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a cohort study to evaluate algorithms for mapping atrial fibrillation by mapping atrial structure and mapping electrical activity to detect physiologically important areas. A key innovation of the observation study is to assess tracking of physiological activity in AF, in relation to tissue activity (MAP recordings), and in relation to AF waves of activity. This observational work extends prior studies that focused on focal and rotational activity, dispersion of electrical activity, low voltage activity and others.
Eligibility Criteria
Inclusion Criteria: * aged 21-80 yrs who underwent electrophysiology study for ablation of Atrial Fibrillation Exclusion Criteria: * Poor data quality of recordings of AF
Contact & Investigator
Sanjiv M Narayan, MD, PhD
PRINCIPAL INVESTIGATOR
Stanford University
Frequently Asked Questions
Who can join the NCT02997254 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 90 Years, studying Atrial Fibrillation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02997254 currently recruiting?
Yes, NCT02997254 is actively recruiting participants. Contact the research team at sanjiv1@stanford.edu for enrollment information.
Where is the NCT02997254 trial being conducted?
This trial is being conducted at Stanford, United States.
Who is sponsoring the NCT02997254 clinical trial?
NCT02997254 is sponsored by Stanford University. The principal investigator is Sanjiv M Narayan, MD, PhD at Stanford University. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.